Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Eur J Cancer. 2024 May;202:114029. doi: 10.1016/j.ejca.2024.114029. Epub 2024 Mar 19.
Childhood cancer survivors (CCS), of whom there are about 500,000 living in Europe, are at an increased risk of developing health problems [1-6] and require lifelong Survivorship Care. There are information and knowledge gaps among CCS and healthcare providers (HCPs) about requirements for Survivorship Care [7-9] that can be addressed by the Survivorship Passport (SurPass), a digital tool providing CCS and HCPs with a comprehensive summary of past treatment and tailored recommendations for Survivorship Care. The potential of the SurPass to improve person-centred Survivorship Care has been demonstrated previously [10,11].
The EU-funded PanCareSurPass project will develop an updated version (v2.0) of the SurPass allowing for semi-automated data entry and implement it in six European countries (Austria, Belgium, Germany, Italy, Lithuania and Spain), representative of three infrastructure healthcare scenarios typically found in Europe. The implementation study will investigate the impact on person-centred care, as well as costs and processes of scaling up the SurPass. Interoperability between electronic health record systems and SurPass v2.0 will be addressed using the Health Level Seven (HL7) International interoperability standards.
PanCareSurPass will deliver an interoperable digital SurPass with comprehensive evidence on person-centred outcomes, technical feasibility and health economics impacts. An Implementation Toolkit will be developed and freely shared to promote and support the future implementation of SurPass across Europe.
PanCareSurPass is a novel European collaboration that will improve person-centred Survivorship Care for CCS across Europe through a robust assessment of the implementation of SurPass v2.0 in different healthcare settings.
欧洲约有 50 万名儿童癌症幸存者(CCS),他们面临着健康问题风险增加[1-6],需要终身接受生存护理。CCS 和医疗保健提供者(HCP)之间存在有关生存护理要求的信息和知识差距[7-9],这些差距可以通过生存护照(SurPass)来解决,这是一种数字工具,可为 CCS 和 HCP 提供过去治疗的综合摘要,并为生存护理提供量身定制的建议。之前已经证明了 SurPass 提高以患者为中心的生存护理的潜力[10,11]。
欧盟资助的 PanCareSurPass 项目将开发 SurPass 的更新版本(v2.0),允许半自动数据输入,并在六个欧洲国家(奥地利、比利时、德国、意大利、立陶宛和西班牙)实施,这些国家代表了欧洲常见的三种基础设施医疗保健情况。实施研究将调查对以患者为中心的护理的影响,以及扩大 SurPass 的成本和流程。使用健康水平 7(HL7)国际互操作性标准解决电子健康记录系统和 SurPass v2.0 之间的互操作性问题。
PanCareSurPass 将提供一个具有全面以患者为中心结果、技术可行性和健康经济学影响证据的互操作数字 SurPass。将开发一个实施工具包并免费共享,以促进和支持 SurPass 在整个欧洲的未来实施。
PanCareSurPass 是一项新颖的欧洲合作,将通过对 SurPass v2.0 在不同医疗保健环境中的实施进行强有力的评估,改善欧洲 CCS 的以患者为中心的生存护理。